target capture
The new Trinity product line cuts out several steps from conventional hybridization-based library prep, with DNA bound to target probes directly on the flow cell.
Twist Bioscience Launches Regulated Products in Europe; Q2 Revenues Jump 25 Percent
The firm is raising its fiscal 2024 revenue guidance to be in the range of $300 million to $304 million, indicating year-over-year growth of 22 to 24 percent.
Celemics, South Dakota State University Create NGS-Based Respiratory Panel for Swine
The assay uses hybridization and next-generation sequencing to detect more than 50 different viruses and bacteria in pigs.
Twist Bioscience, Regeneron Genetics Center Codevelop NGS Genotyping Panel for Population Sequencing
Twist will market the Diversity SNP Panel, which includes approximately 1.4 million SNPs from a globally representative population.
Twist Bioscience, Biotia Nab FDA EUA for Hybridization-Based NGS SARS-CoV-2 Assay
The hybridization-based test may provide better detection of emerging COVID-19 variants of concern, due to a higher tolerance for probe mismatches than in PCR.
Feb 5, 2021
Nov 23, 2020
Jun 2, 2020
May 7, 2020
Twist Bioscience Q2 Revenues Increase 42 Percent
Dec 12, 2019
Oct 24, 2018
Feb 16, 2018
Mar 28, 2017
Nov 2, 2011